<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16412">Lipopolysaccharide</z:chebi> (LPS) preconditioning provides neuroprotection against subsequent cerebral ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNFalpha) is protective in LPS-induced preconditioning yet exacerbates neuronal injury in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we define dual roles of TNFalpha in LPS-induced ischemic tolerance in a murine model of <z:hpo ids='HP_0001297'>stroke</z:hpo> and in primary neuronal cultures in vitro, and show that the cytotoxic effects of TNFalpha are attenuated by LPS preconditioning </plain></SENT>
<SENT sid="3" pm="."><plain>We show that LPS preconditioning significantly increases circulating levels of TNFalpha before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in mice and show that TNFalpha is required to establish subsequent neuroprotection against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, as mice lacking TNFalpha are not protected from ischemic injury by LPS preconditioning </plain></SENT>
<SENT sid="4" pm="."><plain>After <z:hpo ids='HP_0001297'>stroke</z:hpo>, LPS preconditioned mice have a significant reduction in the levels of TNFalpha (approximately threefold) and the proximal TNFalpha signaling molecules, neuronal TNF-receptor 1 (TNFR1), and TNFR-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain (TRADD) </plain></SENT>
<SENT sid="5" pm="."><plain>Soluble TNFR1 (s-TNFR1) levels were significantly increased after <z:hpo ids='HP_0001297'>stroke</z:hpo> in LPS-preconditioned mice (approximately 2.5-fold), which may neutralize the effect of TNFalpha and reduce TNFalpha-mediated injury in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, LPS-preconditioned mice show marked resistance to brain injury caused by intracerebral administration of exogenous TNFalpha after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We establish an in vitro model of LPS preconditioning in primary cortical neuronal cultures and show that LPS preconditioning causes significant protection against injurious TNFalpha in the setting of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Our studies suggest that TNFalpha is a twin-edged sword in the setting of <z:hpo ids='HP_0001297'>stroke</z:hpo>: TNFalpha upregulation is needed to establish LPS-induced tolerance before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, whereas suppression of TNFalpha signaling during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> confers neuroprotection after LPS preconditioning </plain></SENT>
</text></document>